Mind Medicine (MindMed) (MNMD) News Today $7.15 +0.01 (+0.14%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$7.20 +0.05 (+0.70%) As of 09:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial OfficerMay 27 at 6:41 PM | finance.yahoo.comHC Wainwright Issues Pessimistic Forecast for MNMD EarningsMay 27 at 1:41 AM | americanbankingnews.comHC Wainwright Has Pessimistic Outlook of MNMD Q3 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - HC Wainwright lowered their Q3 2025 EPS estimates for Mind Medicine (MindMed) in a report issued on Wednesday, May 21st. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of ($0.36) for the quarteMay 27 at 1:35 AM | marketbeat.comWhat is HC Wainwright's Estimate for MNMD Q1 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Mind Medicine (MindMed) in a note issued to investors on Wednesday, May 21st. HC Wainwright analyst P. Trucchio anticipates that the cMay 25, 2025 | marketbeat.comCantor Fitzgerald Has Negative View of MNMD FY2025 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for shares of Mind Medicine (MindMed) in a research report issued on Wednesday, May 21st. Cantor Fitzgerald analyst C. Duncan now anticipates that thMay 25, 2025 | marketbeat.comCantor Fitzgerald Analysts Cut Earnings Estimates for MNMDMay 25, 2025 | americanbankingnews.comWhat is HC Wainwright's Forecast for MNMD Q1 Earnings?May 25, 2025 | americanbankingnews.comNorthern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Northern Trust Corp grew its position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 684,836 shares of the company's stock after buMay 24, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Acquired by AWM Investment Company Inc.AWM Investment Company Inc. lifted its position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 39.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,193,162 shares of the company's stock after buying an additiMay 23, 2025 | marketbeat.comTang Capital Management LLC Acquires New Shares in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Tang Capital Management LLC acquired a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 200,000 shares of the company's stock, valued at approximately $1,392,000. Tang CapitMay 20, 2025 | marketbeat.comMindMed Announces New Employee Inducement GrantsMay 19, 2025 | businesswire.comCantor Fitzgerald Upgrades Mind Medicine (MindMed) (NASDAQ:MNMD) to "Strong-Buy"Cantor Fitzgerald upgraded shares of Mind Medicine (MindMed) to a "strong-buy" rating in a research report on Tuesday.May 17, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by AnalystsShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have earned a consensus rating of "Buy" from the thirteen analysts that are currently covering the company, Marketbeat reports. Ten investment analysts have rated the stock with a buy rating and three have given a strong buy ratMay 17, 2025 | marketbeat.comCantor Fitzgerald Forecasts MNMD FY2025 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Mind Medicine (MindMed) in a report issued on Monday, May 12th. Cantor Fitzgerald analyst C. Duncan expects that the company will earMay 16, 2025 | marketbeat.comChardan Capital Reaffirms "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD)Chardan Capital restated a "buy" rating and issued a $20.00 price objective on shares of Mind Medicine (MindMed) in a report on Friday.May 11, 2025 | marketbeat.comDriehaus Capital Management LLC Cuts Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Driehaus Capital Management LLC decreased its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 13.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,376,207 shares oMay 11, 2025 | marketbeat.comEarnings call transcript: MindMed Q1 2025 results show mixed signalsMay 10, 2025 | uk.investing.comDeep Track Capital LP Has $19.60 Million Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Deep Track Capital LP lowered its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 60.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,816,594 shares of the company's stock after selling 4,248,505 shMay 9, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comMind Medicine (MindMed) Inc. 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comMindMed Reports First Quarter 2025 Financial Results and Recent Business UpdatesMay 8, 2025 | businesswire.comBlackstone Inc. Trims Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Blackstone Inc. decreased its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 8.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,587,479 shares of the company's stock after selling 325,000 shares durinMay 8, 2025 | marketbeat.comMind Medicine Q1 2025 Earnings PreviewMay 7, 2025 | msn.comAllostery Investments LP Invests $905,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Allostery Investments LP acquired a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 130,000 shares of the company's stock, valued at approximately $905,000. Mind Medicine (May 4, 2025 | marketbeat.comAlly Bridge Group NY LLC Sells 458,233 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Ally Bridge Group NY LLC reduced its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 58.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 330,275 shares of the company's stock after selling 458,23May 4, 2025 | marketbeat.comMind Medicine (MindMed) (MNMD) to Release Earnings on ThursdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-mind-medicine-mindmed-inc-stock/)May 3, 2025 | marketbeat.comTri Locum Partners LP Decreases Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Tri Locum Partners LP lowered its position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 50.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 820,793 shares of the cApril 29, 2025 | marketbeat.comMindMed to Report First Quarter 2025 Financial Results on May 8, 2025April 24, 2025 | businesswire.comInstitutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)April 24, 2025 | finance.yahoo.comMarshall Wace LLP Purchases 213,526 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Marshall Wace LLP grew its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,501,391 shares of the compaApril 23, 2025 | marketbeat.comGeode Capital Management LLC Acquires 45,386 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Geode Capital Management LLC lifted its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 2.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,723,088 shares of the compaApril 23, 2025 | marketbeat.comQ1 Earnings Estimate for MNMD Issued By Leerink PartnrsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Mind Medicine (MindMed) in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman anticipates that the company will post eApril 18, 2025 | marketbeat.comMindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)April 15, 2025 | finance.yahoo.comWhat is Chardan Capital's Forecast for MNMD FY2025 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at Chardan Capital issued their FY2025 earnings per share estimates for Mind Medicine (MindMed) in a report released on Monday, March 24th. Chardan Capital analyst R. Li anticipates that the company will earn ($1.70) perMarch 28, 2025 | marketbeat.comBIT Capital GmbH Acquires New Shares in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)BIT Capital GmbH bought a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 63,405 shares of the company'March 28, 2025 | marketbeat.comCarrie Liao Sells 2,347 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CAO Carrie Liao sold 2,347 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The shares were sold at an average price of $6.74, for a total transaction of $15,818.78. Following the transaction, the chief accounting officer now directly owns 144,923 shares in the company, valued at $976,781.02. The trade was a 1.59 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.March 27, 2025 | marketbeat.comInsider Selling: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Sells 6,836 Shares of StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Daniel Karlin sold 6,836 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The stock was sold at an average price of $6.74, for a total transaction of $46,074.64. Following the sale, the insider now owns 446,177 shares of the company's stock, valued at $3,007,232.98. This represents a 1.51 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.March 27, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $142,941.92 in StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 21,208 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The shares were sold at an average price of $6.74, for a total value of $142,941.92. Following the completion of the sale, the chief executive officer now directly owns 856,556 shares of the company's stock, valued at $5,773,187.44. This trade represents a 2.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.March 27, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CAO Carrie Liao Sells 2,347 SharesMarch 27, 2025 | insidertrades.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned a consensus rating of "Buy" from the thirteen research firms that are presently covering the company, Marketbeat.com reports. Ten research analysts have rated the stock with a buy recommendation and three have issued a strongMarch 26, 2025 | marketbeat.comMind Medicine appoints Matt Wiley as CCOMarch 18, 2025 | markets.businessinsider.comMindMed Appoints Matt Wiley as Chief Commercial OfficerMarch 17, 2025 | businesswire.comWealthfront Advisers LLC Buys New Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Wealthfront Advisers LLC bought a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 103,086 shares of the company's stock, valued at approximately $717,000March 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for MNMD FY2029 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - HC Wainwright upped their FY2029 earnings estimates for Mind Medicine (MindMed) in a research note issued to investors on Friday, March 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn $2.86 per share forMarch 10, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Price Target Cut to $16.00 by Analysts at Robert W. BairdRobert W. Baird dropped their target price on shares of Mind Medicine (MindMed) from $27.00 to $16.00 and set an "outperform" rating for the company in a research report on Friday.March 8, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Friday.March 8, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPSMind Medicine (MindMed) (NASDAQ:MNMD - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.08). During the same period in the prior year, the business posted ($0.59) earnings per share.March 7, 2025 | marketbeat.comMind Medicine (MindMed) Inc. 2024 Q4 - Results - Earnings Call PresentationMarch 6, 2025 | seekingalpha.comMindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business UpdatesMarch 6, 2025 | finance.yahoo.comPsychedelic: MindMed reports Q4 earnings resultsMarch 6, 2025 | markets.businessinsider.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.290.87▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼193▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APLS News MIRM News ARWR News VCEL News KNSA News HRMY News DNLI News BLTE News CGON News NAMS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNMD Stock Free MNMD Stock Alerts